Treatment (n = 6) | Mean increase in paw volume in ml ± SEM (% inhibition) | ||
---|---|---|---|
1 h | 2 h | 3 h | |
5% Tween-20, 10 ml/kg | 0.85 ± 0.07 (-) | 0.83 ± 0.08 (-) | 0.85 ± 0.05 (-) |
ASA 200 mg/kg | 0.83 ± 0.02 (2.35) | 0.78 ± 0.05 (6.02) | 0.55 ± 0.08*(35.29) |
HAE 150 mg/kg | 0.93 ± 0.01 (-9.41) | 0.79 ± 0.02 (4.82) | 0.60 ± 0.04*(29.41) |
HAE 300 mg/kg | 0.50 ± 0.03* (41.17) | 0.78 ± 0.06 (6.02) | 0.57 ± 0.09*(32.94) |
HAE 600 mg/kg | 0.75 ± 0.08 (11.76) | 0.67 ± 0.09 (19.28) | 0.58 ± 0.07*(31.76) |
Treatment (n = 6) | Mean increase in paw volume in ml ± SEM (% inhibition) | ||
---|---|---|---|
1 h | 2 h | 3 h | |
5% Tween-20, 10 ml/kg | 0.39 ± 0.02 (-) | 0.44 ± 0.04 (-) | 0.33 ± 0.04 (-) |
ASA 200 mg/kg | 0.27 ± 0.02*(30.77) | 0.21 ± 0.02*(52.27) | 0.21 ± 0.01*(36.36) |
HAE 150 mg/kg | 0.36 ± 0.03 (7.69) | 0.29 ± 0.04*(34.09) | 0.25 ± 0.03*(24.24) |
HAE 300 mg/kg | 0.28 ± 0.03*(28.21) | 0.24 ± 0.05*(45.45) | 0.22 ± 0.05*(33.33) |
HAE 600 mg/kg | 0.31 ± 0.02*(20.51) | 0.24 ± 0.03*(45.45) | 0.22 ± 0.03*(33.33) |
Treatment (n = 6) | PRT (sec) | % inhibition |
---|---|---|
5% tween-20, 10 ml/kg | 2.10 ± 0.21 | - |
Pentazocine 3 mg/kg | 3.52 ± 0.41* | 67.62 |
HAE 150 mg/kg | 2.50 ± 0.08* | 19.05 |
HAE 300 mg/kg | 2.84 ± 0.24* | 35.24 |
HAE 600 mg/kg | 2.58 ± 0.15* | 22.86 |
Treatment (n = 6) | Mean writhing number | % inhibition |
---|---|---|
5% Tween-20, 10 ml/kg | 21.80 ± 0.48 | - |
ASA 200 mg/kg | 7.00 ± 0.58* | 67.89 |
HAE 150 mg/kg | 19.80 ± 0.87* | 9.17 |
HAE 300 mg/kg | 17.60 ± 0.66* | 19.27 |
HAE 600 mg/kg | 14.00 ± 0.58* | 35.78 |